Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
Would you offer radiation therapy for ovarian remnant syndrome?
If so, what dose would you recommend? What other management options would you consider?
Answer from: Radiation Oncologist at Community Practice
I have treated a few times with mixed results to a dose of around 20 Gy.
Sign In
or
Register
to read more
Answer from: at Community Practice
Yes
Sign In
or
Register
to read more
13056
24778
Related Questions
Does being on maintenance pembrolizumab change how you manage patients with partial metabolic response on PET/CT 3 months after chemoradiation for cervical cancer?
In patients treated with the KEYNOTE A-18 regimen who later recur, would you rechallenge with immunotherapy again?
When utilizing KN-A18 protocol, how do you best address symptoms of colitis/cystitis?
How have you incorporated ctDNA into the clinical management of patients with gynecologic cancers?
Would you treat with extended field pelvic radiation for a patient with FIGO IIIC1 endometrial cancer who was found with isolated tumor cells (ITCs) on a single paraaortic sentinel lymph node?
What strategies do you find helpful in advanced care planning with patients/families who are very "miracle" centered?
What screening tools or signs do you use to predict if a cancer patient is near end-of-life?
How do you approach adjuvant radiation recommendations for low-risk endometrial cancer in which the patient was unable to undergo pelvic sentinel node mapping?
Are there patient populations in whom you would consider using both induction chemotherapy and maintenance pembrolizumab for a patient with locally advanced cervical cancer?
Between KEYNOTE A-18 and INTERLACE, for which patients would you recommend using one protocol over another?